Association between insulin resistance with gynaecological cancers in non-diabetic wome
Not Applicable
- Conditions
- Health Condition 1: C55- Malignant neoplasm of uterus, partunspecified
- Registration Number
- CTRI/2024/08/072032
- Lead Sponsor
- Dr Parish Kamdi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All non-diabetic women with endometrial, ovarian and cervical cancers who are willing to participate
Exclusion Criteria
Women with Diabetes Mellitus
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Homeostatic model assessment -insulin resistance calculated as fasting insulin (microU/L) X fasting plasma glucose (mol/L)Timepoint: Once at the time of recruitment
- Secondary Outcome Measures
Name Time Method Age, menopausal status, parity, history of contraception, smoking or drinking habits, education status, family history of female genital cancer, family history of diabetes, weight, height, BMI, waist circumference, hip circumference, blood pressure, lipid profile , fasting plasma glucose, fasting insulin, HbA1c.Timepoint: Once at the time of recruitment